Boothbay Fund Management, LLC Adverum Biotechnologies, Inc. Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$2.87 - $5.92 $74,215 - $153,085	-25,859 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$4.5 - $7.6 $9,639 - $16,279	2,142 Added 9.03%	25,859 $156,000
Q2 2018 Aug 14, 2018	SELL	$5.3 - $6.9 $579,364 - $754,266	-109,314 Reduced 82.17%	23,717 $126,000
Q1 2018 May 14, 2018	BUY	$3.65 - $7.95 $308,136 - $671,146	84,421 Added 173.67%	133,031 $772,000
Q4 2017 Feb 14, 2018	BUY	$2.85 - $3.95 $138,538 - $192,009	48,610	48,610 $170,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.